Works matching IS 09395555 AND DT 2023 AND VI 102 AND IP 10

Results: 38
    1
    2

    A novel germline hyperactivating JAK2 mutation L604F.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2725, doi. 10.1007/s00277-023-05423-y
    By:
    • Dvořáček, Lukáš;
    • Marková, Jana;
    • Holoubek, Aleš;
    • Grebeňová, Dana;
    • Kundrát, David;
    • Kuželová, Kateřina;
    • Schwarz, Jiří
    Publication type:
    Article
    3

    Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2903, doi. 10.1007/s00277-023-05396-y
    By:
    • Cremer, Anjali;
    • Enssle, Julius C.;
    • Pfaff, Saskia;
    • Kouidri, Khouloud;
    • Lang, Fabian;
    • Brandts, Christian;
    • Zeiher, Andreas;
    • Cremer, Sebastian;
    • Steffen, Björn;
    • Serve, Hubert;
    • Bug, Gesine
    Publication type:
    Article
    4

    Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2741, doi. 10.1007/s00277-023-05394-0
    By:
    • Isfort, Susanne;
    • Manz, Kirsi;
    • Teichmann, Lino L.;
    • Crysandt, Martina;
    • Burchert, Andreas;
    • Hochhaus, Andreas;
    • Saussele, Susanne;
    • Kiani, Alexander;
    • Göthert, Joachim R.;
    • Illmer, Thomas;
    • Schafhausen, Philippe;
    • Al-Ali, Haifa Kathrin;
    • Stegelmann, Frank;
    • Hänel, Mathias;
    • Pfeiffer, Tim;
    • Giagounidis, Aristoteles;
    • Franke, Georg-Nikolaus;
    • Koschmieder, Steffen;
    • Fabarius, Alice;
    • Ernst, Thomas
    Publication type:
    Article
    5

    Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2895, doi. 10.1007/s00277-023-05410-3
    By:
    • Kurita, Naoki;
    • Nishikii, Hidekazu;
    • Maruyama, Yumiko;
    • Suehara, Yasuhito;
    • Hattori, Keiichiro;
    • Sakamoto, Tatsuhiro;
    • Kato, Takayasu;
    • Yokoyama, Yasuhisa;
    • Obara, Naoshi;
    • Maruo, Kazushi;
    • Ohigashi, Tomohiro;
    • Yamaguchi, Hitomi;
    • Iwamoto, Toshiro;
    • Minohara, Hideto;
    • Matsuoka, Ryota;
    • Hashimoto, Koichi;
    • Sakata-Yanagimoto, Mamiko;
    • Chiba, Shigeru
    Publication type:
    Article
    6

    Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2695, doi. 10.1007/s00277-023-05400-5
    By:
    • Duan, Wenbing;
    • Yang, Sen;
    • Zhao, Ting;
    • Hu, Lijuan;
    • Qin, Yazhen;
    • Jia, Jinsong;
    • Wang, Jing;
    • Lu, Shengye;
    • Jiang, Hao;
    • Zhang, Xiaohui;
    • Xu, Lanping;
    • Wang, Yu;
    • Lai, Yueyun;
    • Shi, Hongxia;
    • Huang, Xiaojun;
    • Jiang, Qian
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    One disease, two faces: clonally-related AML and MPDCP with skin involvement.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2969, doi. 10.1007/s00277-023-05377-1
    By:
    • Martino, Giovanni;
    • Cimino, Gaetano;
    • Caridi, Matteo;
    • Perta, Giuseppe;
    • Cardinali, Valeria;
    • Sciabolacci, Sofia;
    • Quintini, Martina;
    • Matteucci, Caterina;
    • Ascani, Stefano;
    • Mecucci, Cristina;
    • Martelli, Maria Paola
    Publication type:
    Article
    18
    19

    The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2791, doi. 10.1007/s00277-023-05385-1
    By:
    • Fischer, Luca;
    • Jiang, Linmiao;
    • Bittenbring, Joerg Thomas;
    • Huebel, Kai;
    • Schmidt, Christian;
    • Duell, Johannes;
    • Metzner, Bernd;
    • Krauter, Juergen;
    • Glass, Bertram;
    • Huettmann, Andreas;
    • Schaefer-Eckart, Kerstin;
    • Silkenstedt, Elisabeth;
    • Klapper, Wolfram;
    • Hiddemann, Wolfgang;
    • Unterhalt, Michael;
    • Dreyling, Martin;
    • Hoster, Eva
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2879, doi. 10.1007/s00277-023-05356-6
    By:
    • Araie, Hiroaki;
    • Arai, Yasuyuki;
    • Kida, Michiko;
    • Aoki, Jun;
    • Uchida, Naoyuki;
    • Doki, Noriko;
    • Fukuda, Takahiro;
    • Tanaka, Masatsugu;
    • Ozawa, Yukiyasu;
    • Sawa, Masashi;
    • Katayama, Yuta;
    • Matsuo, Yayoi;
    • Onizuka, Makoto;
    • Kanda, Yoshinobu;
    • Kawakita, Toshiro;
    • Kanda, Junya;
    • Atsuta, Yoshiko;
    • Yanada, Masamitsu
    Publication type:
    Article
    26

    Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2815, doi. 10.1007/s00277-023-05352-w
    By:
    • Goveia, Lilian;
    • Castro, Nelson;
    • de Souza, Carmino;
    • Colaço Villarim, Carolina;
    • Traina, Fabiola;
    • Chiattone, Carlos Sergio;
    • Praxedes, Monica;
    • Solza, Cristiana;
    • Perobelli, Leila;
    • Baiocchi, Otavio;
    • Gaiolla, Rafael;
    • Boquimpani, Carla;
    • Buccheri, Valeria;
    • Bonamin Sola, Caroline;
    • de Oliveira Paula e Silva, Roberta;
    • Ribas, Ana Carolina;
    • Steffenello, Giovanna;
    • Pagnano, Katia;
    • Soares, Andrea;
    • Souza Medina, Samuel
    Publication type:
    Article
    27
    28
    29
    30
    31

    Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2835, doi. 10.1007/s00277-023-05351-x
    By:
    • Roy Moulik, Nirmalya;
    • Keerthivasagam, Swaminathan;
    • Velagala, Swetha V.;
    • Gollamudi, Venkata Rama Mohan;
    • Agiwale, Jayesh;
    • Dhamne, Chetan;
    • Chichra, Akanksha;
    • Srinivasan, Shyam;
    • Shetty, Dhanlaxmi;
    • Jain, Hemani;
    • Subramanian, Papagudi G.;
    • Tembhare, Prashant;
    • Chatterjee, Gaurav;
    • Patkar, Nikhil;
    • Narula, Gaurav;
    • Banavali, Shripad
    Publication type:
    Article
    32
    33
    34

    Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2909, doi. 10.1007/s00277-023-05209-2
    By:
    • Iemura, Tomoki;
    • Kondo, Tadakazu;
    • Ueda, Atsushi;
    • Maeda, Takeshi;
    • Kitawaki, Toshio;
    • Arai, Yasuyuki;
    • Kanda, Junya;
    • Ikeda, Takashi;
    • Imada, Kazunori;
    • Ishikawa, Takayuki;
    • Anzai, Naoyuki;
    • Itoh, Mitsuru;
    • Takeoka, Tomoharu;
    • Akasaka, Takashi;
    • Yago, Kazuhiro;
    • Yonezawa, Akihito;
    • Arima, Nobuyoshi;
    • Kitano, Toshiyuki;
    • Nohgawa, Masaharu;
    • Watanabe, Mitsumasa
    Publication type:
    Article
    35
    36
    37
    38